Rheumatic Heart Disease Clinical Features Diagnosis Management and Prevention
medicine

Rheumatic Heart Disease Clinical Features Diagnosis Management and Prevention


Rheumatic Heart Disease (RHD)

1. Definition

Rheumatic Heart Disease is a chronic, progressive valvular heart disease resulting from immune-mediated damage following acute rheumatic fever (ARF), itself a sequela of untreated or inadequately treated Group A β-hemolytic streptococcal (GAS) pharyngitis. It predominantly affects the mitral valve, followed by the aortic valve, leading to stenosis, regurgitation, or mixed lesions.


2. Epidemiology

  • Predominantly affects children and young adults in low- and middle-income countries
  • Major cause of acquired heart disease in the young
  • High burden in South Asia, Sub-Saharan Africa, Pacific Islands
  • Female predominance (especially mitral stenosis)

3. Etiology and Risk Factors

Primary cause

  • Autoimmune response to GAS pharyngitis

Risk factors

  • Recurrent untreated sore throat
  • Poverty, overcrowding
  • Limited access to healthcare
  • Poor adherence to secondary prophylaxis
  • Genetic susceptibility (HLA associations)

4. Pathophysiology

  1. GAS infection → molecular mimicry
  2. Cross-reactive antibodies and T-cells target cardiac tissue
  3. Pancarditis during ARF
  4. Chronic inflammation → fibrosis, commissural fusion, leaflet thickening
  5. Progressive valvular deformity and dysfunction

Valve involvement (frequency)

  • Mitral valve: ~70%
  • Aortic valve: ~25%
  • Tricuspid valve: ~5% (usually secondary)
  • Pulmonary valve: rare

5. Valve-Specific Lesions

Mitral stenosis

  • Commissural fusion
  • “Fish-mouth” valve
  • Left atrial enlargement → atrial fibrillation → thromboembolism

Mitral regurgitation

  • Leaflet retraction
  • Chordal elongation or rupture

Aortic stenosis

  • Cusp thickening and fusion

Aortic regurgitation

  • Cusp retraction

6. Clinical Features

A. Acute Rheumatic Fever (preceding illness)

  • Migratory polyarthritis
  • Carditis (tachycardia, murmurs, cardiomegaly)
  • Chorea
  • Subcutaneous nodules
  • Erythema marginatum

B. Chronic Rheumatic Heart Disease

Depends on valve involved:

Mitral stenosis

  • Dyspnea, orthopnea, PND
  • Hemoptysis
  • Palpitations (AF)
  • Stroke or systemic embolism

Mitral regurgitation

  • Fatigue
  • Dyspnea
  • Signs of left ventricular failure

Aortic valve disease

  • Exertional dyspnea
  • Angina
  • Syncope (AS)
  • Bounding pulse (AR)

Advanced disease

  • Right heart failure
  • Ascites, pedal edema
  • Cachexia

7. Physical Examination

General

  • Malar flush (mitral stenosis)
  • Irregularly irregular pulse (AF)

Cardiac auscultation

  • MS: Loud S1, opening snap, mid-diastolic murmur
  • MR: Pansystolic murmur at apex radiating to axilla
  • AS: Ejection systolic murmur radiating to carotids
  • AR: Early diastolic decrescendo murmur

8. Investigations

A. Laboratory

  • Evidence of prior streptococcal infection:

* Elevated ASO titre

* Anti-DNase B

  • Inflammatory markers (during ARF)

B. ECG

  • Atrial fibrillation
  • Left atrial enlargement
  • Ventricular hypertrophy

C. Chest X-ray

  • Cardiomegaly
  • Left atrial enlargement
  • Pulmonary congestion

D. Echocardiography (gold standard)

  • Valve morphology
  • Severity of stenosis/regurgitation
  • Chamber sizes
  • Pulmonary artery pressure
  • Detection of LA thrombus

E. Transesophageal Echo

  • Before cardioversion or balloon valvotomy

9. Diagnostic Criteria

Jones Criteria for Acute Rheumatic Fever:

  • Major: Carditis, polyarthritis, chorea, erythema marginatum, subcutaneous nodules
  • Minor: Fever, arthralgia, elevated ESR/CRP, prolonged PR interval
  • Plus evidence of recent GAS infection

10. Differential Diagnosis

  • Degenerative valvular disease
  • Congenital valve disease
  • Infective endocarditis
  • Dilated cardiomyopathy
  • Hypertrophic cardiomyopathy

11. Management

A. Acute Rheumatic Fever

1. Eradication of GAS

Benzathine penicillin G

  • Indication: Confirmed or suspected GAS infection
  • Dose:

* Adults: 1.2 million units IM single dose

* Children <27 kg: 600,000 units IM

  • MOA: Inhibits bacterial cell wall synthesis
  • Adverse effects: Allergy, anaphylaxis
  • Contraindications: Penicillin allergy
  • Alternative: Azithromycin or erythromycin

2. Anti-inflammatory therapy

Aspirin

  • Dose: 60–100 mg/kg/day in divided doses
  • Indication: Arthritis
  • Adverse effects: Gastritis, bleeding
  • Monitoring: Salicylate toxicity

Corticosteroids

  • Indication: Severe carditis with heart failure
  • Example: Prednisolone 1–2 mg/kg/day

B. Chronic Rheumatic Heart Disease

1. Secondary Prophylaxis (most critical)

Benzathine penicillin G

  • Dose: 1.2 million units IM every 3–4 weeks
  • Duration:

* No carditis: 5 years or until age 21

* Carditis, no residual disease: 10 years or until 21

* Residual valvular disease: ≥10 years or lifelong


2. Medical Management (symptom-based)

Diuretics (e.g., Furosemide)

  • Indication: Congestive symptoms
  • MOA: Loop diuretic
  • Monitoring: Electrolytes

Beta-blockers

  • Indication: Rate control in AF, MS
  • Example: Metoprolol

Digoxin

  • Indication: AF with heart failure
  • Monitoring: Serum levels, toxicity

Anticoagulation

  • Indication:

* AF

* Prior embolism

* LA thrombus

  • Drug: Warfarin
  • Target INR: 2.0–3.0
  • Contraindications: Pregnancy (1st trimester)

3. Interventional and Surgical Management

Percutaneous balloon mitral valvotomy

  • Indication: Symptomatic severe MS with favorable valve anatomy
  • Contraindications: LA thrombus, significant MR

Valve repair or replacement

  • Indications:

* Severe symptomatic valve disease

* LV dysfunction

  • Mechanical valve → lifelong anticoagulation
  • Bioprosthetic valve → limited durability

12. Complications

  • Atrial fibrillation
  • Thromboembolism
  • Infective endocarditis
  • Heart failure
  • Pulmonary hypertension
  • Stroke

13. Prognosis

  • Depends on:

* Severity of valve involvement

* Adherence to secondary prophylaxis

* Timely intervention

  • Early detection and prophylaxis dramatically reduce progression

14. Prevention

Primary prevention

  • Early diagnosis and treatment of streptococcal pharyngitis

Secondary prevention

  • Long-term penicillin prophylaxis

Public health measures

  • Improved living conditions
  • Access to primary healthcare
  • School-based sore throat programs

15. Key Clinical Pearls

  • Mitral stenosis in a young patient → think RHD
  • Secondary prophylaxis saves valves and lives
  • Echocardiography is essential even in asymptomatic patients
  • AF + RHD = anticoagulate unless contraindicated

Interactive MCQ Quiz

MCQ Exam Mode

15 Questions
Question 1 of 15

Frequently Asked Questions

Rheumatic heart disease is a chronic valvular heart condition caused by immune-mediated damage following acute rheumatic fever, which occurs after untreated or inadequately treated Group A streptococcal throat infection.
The mitral valve is most commonly affected, followed by the aortic valve. Tricuspid involvement is usually secondary, and pulmonary valve involvement is rare.
Acute rheumatic fever causes an autoimmune reaction due to molecular mimicry between streptococcal antigens and cardiac tissue, leading to inflammation, fibrosis, and permanent valvular damage.
Common symptoms include exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, hemoptysis, palpitations due to atrial fibrillation, and thromboembolic events such as stroke.
Left atrial enlargement due to mitral stenosis or regurgitation predisposes to atrial fibrillation, increasing the risk of thromboembolism.
Echocardiography is the gold standard investigation as it defines valve morphology, severity of stenosis or regurgitation, chamber sizes, pulmonary pressures, and complications like atrial thrombus.
Secondary prophylaxis with long-acting benzathine penicillin prevents recurrent streptococcal infections and recurrent rheumatic fever, thereby slowing progression of valvular damage.
Duration depends on severity: at least 5 years or until age 21 without carditis, 10 years or until age 21 with carditis, and often lifelong in patients with residual valvular disease.
It is indicated in symptomatic severe rheumatic mitral stenosis with favorable valve anatomy and absence of left atrial thrombus or significant mitral regurgitation.
Warfarin is preferred because clinical trials have shown inferior protection with direct oral anticoagulants in rheumatic mitral stenosis.
Complications include atrial fibrillation, thromboembolism, infective endocarditis, pulmonary hypertension, heart failure, stroke, and sudden cardiac death.
Pregnancy increases blood volume and heart rate, which can precipitate pulmonary edema and heart failure, especially in mitral stenosis.
Ortner syndrome refers to hoarseness of voice due to compression of the left recurrent laryngeal nerve by an enlarged left atrium in severe mitral stenosis.
Valve surgery is indicated in severe symptomatic valvular disease, presence of left ventricular dysfunction, or when percutaneous intervention is not suitable.
Prevention includes early treatment of streptococcal pharyngitis, long-term secondary prophylaxis after rheumatic fever, improved living conditions, and access to primary healthcare.